Climate Technology Centre and Network… Revisiting the Climate Change, Technology Transfer and IP Debate (Part II): What did we learn from COVID? 6 Nov 202411 Nov 2024 In 2021, intellectual property again became an issue in international discussions on access to COVID19 vaccines. As with the debate over access to HIV medications in the early 2000’s, the…
Emerging Economies… Going Green: Navigating Intellectual Property Law in Times of Global Challenges and Sustainability Transitions 14 Oct 202411 Oct 2024 ASIL Panel Presentation - https://www.youtube.com/live/ZsXyRu5nvCM On September 27, 2024 I was on a panel discussion on the evolving role of intellectual property law in fostering innovation, diffusion, and the transfer…
Access to Medicines… Here Again?! – The WTO COVID19 Waiver Ministerial Decision- June 2022 17 Jun 202217 Jun 2022 In a previous piece in the Conversation and on this Blog I predicted that the final outcome of the negotiations on the TRIPS Waiver would end up with a solution…
Access to Medicines… A Compulsory License Option for the COVID19 TRIPS Waiver Proposal 15 Apr 202116 Apr 2021 In a recent news piece, I argued that while I support the proposal from India, South Africa and other countries for a temporary waiver of TRIPS obligations, my assessment is…
Access to Medicines… How to get COVID-19 vaccines to poor countries – and still keep patent benefits for drugmakers 15 Apr 202115 Apr 2021 How to get COVID-19 vaccines to poor countries – and still keep patent benefits for drugmakers Hospital staff in Lagos, Nigeria, administer the AstraZeneca vaccine. AP Photo/Sunday Alamba Dalindyebo Shabalala,…
Access to Medicines… Can Countries use TRIPS Article 31 (Compulsory Licensing) to address COVID Vaccine shortages? 23 Feb 2021 (for a longer treatment on the availability of unilateral measures under TRIPS, I recommend Chapter 6 of my PhD Climate Change, Technology Transfer and Intellectual Property: Options for Action at…
Access to Medicines… Can Countries use TRIPS Article 30 to take Unilateral Action to Address COVID Vaccine shortages? 22 Feb 2021 (For a longer treatment on the availability of unilateral measures under TRIPS, I recommend Chapter 6 of my PhD Climate Change, Technology Transfer and Intellectual Property: Options for Action at…
Access to Medicines… Is COVID Manufacturing Capacity actually limited or is Intellectual Property the problem? 19 Feb 2021 Supply of the Moderna and BioNTech/Pfizer (and others) vaccines is likely not to keep up with the supply commitments made by both companies. News reports suggest that they are only…
IPCC… GHG emissions peaking and the pace of distribution of climate technologies 7 Jun 20186 Jun 2018 Shubha Ghosh at Syracuse University School of Law was a wonderful host for a symposium on April 25th on Technology & Policy Responses to Climate Disruption. The agenda is available…
Definitions… Which climate technologies do we need to have developed and diffused? 26 Aug 2016 As we begin to move into the implementation phase of the Paris Climate Agreement, it seems appropriate to revisit and assess some questions relating to intellectual property and climate change. …
Technology, Sustainability & Human Rights 